A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: The Multiple Sclerosis Relapse Management Scale (MSRMS)

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Riazi, Afsane ^a,b   Porter, Bernadette ^c   Chataway, Jeremy ^c   Thompson, Alan J ^b,c   Hobart, Jeremy C ^b,d  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONCEPTUAL FRAMEWORK; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH CARE ACCESS; HOME INTRAVENOUS THERAPY; HOSPITAL MANAGEMENT; HUMAN; INTERVIEW; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS RELAPSE MANAGEMENT SCALE; PSYCHOMETRY; RATING SCALE; RELAPSE; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOME CARE; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; OUTPATIENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TREATMENT OUTCOME;

STEROID;

ADOLESCENT; ADULT; AGED; FEMALE; HOME CARE SERVICES; HUMANS; INFUSIONS, INTRAVENOUS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); OUTPATIENTS; PATIENT SATISFACTION; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; STEROIDS;

EID: 80053376271     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-80     Document Type: Article

References (29)

1. Runnmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993, 116:117-134. 10.1093/brain/116.1.117, 8453453.
2. Barnes D, Hughes RAC, Morris RW, Wade-Jones O, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi H, Farmer S, Frankel J. Randomised trial of oral and intravenous methhylprednisolone in acute relapses of multiple sclerosis. Lancet 1997, 349:902-6. 10.1016/S0140-6736(96)06453-7, 9093250.
3. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003, 61(11):1528-32.
4. Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sorensen PS, . EFNS Task Force on Treatment of Multiple Sclerosis Relapses EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol 2005, 12(12):939-46. 10.1111/j.1468-1331.2005.01352.x, 16324087, EFNS Task Force on Treatment of Multiple Sclerosis Relapses.
5. Borras JM, Sanchez-Hernandez A, Navarro M, Martinez M, Mendez E, Ponton JL, Espinas JA, Germa JR. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial. BMJ 2001, 322:826-28. 10.1136/bmj.322.7290.826, 30558, 11290635.
6. Richards DA, Toop LJ, Epton MJ, McGeoch GR, Town GI, Wynn-Thomas SM, Dawson RD, Hlavac MC, Werno AM, Abernethey PD. Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial. Med J Aust 2005, 183:235-38.
7. Corwin P, Toop LJ, McGeoch G, Than M, Wynn-Thomas S, Wells E, Dawson R, Abernethey P, Pithie A, Chambers S, Fletcher L, Richards D. Randomised controlled trial of intravenous antibiotic treatment for cellulites at home compared with hospital. BMJ 2005, 330:129-32. 10.1136/bmj.38309.447975.EB, 544431, 15604157.
8. Fitzpatrick R, Hopkins A. Problems in the conceptual framework of patient satisfaction research: and empirical exploration. Sociol Health Illness 1983, 5:297-311.
9. Kuckartz U. WINMAX pro '96 - Scientific Text Analysis. 1996, Berlin: Sage Publications.
10. Hobart JC, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001, 124:962-973. 10.1093/brain/124.5.962, 11335698.
11. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology 2003, 60:31-6.
12. Nunnally JC, Bernstein IH. Psychometric Theory. 1994, New York: McGraw-Hill, 3.
13. Hobart JC, Freeman J, Lamping D, Fitzpatrick R, Thompson A. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 2001, 71:363-70. 10.1136/jnnp.71.3.363, 1737568, 11511712.
14. Likert RA. A technique for the development of attitudes. Arch Psychol 1932, 140:5-55.
15. Stewart AL, Ware JE, . eds Measuring functioning and well-being: the medical outcomes study approach. 1992, Durham (NC): Duke University Press, eds.
16. Eisen M, Ware JE, Donald CA, Brooke RH. Measuring components of children's health status. Medical Care 1979, 17:902-21. 10.1097/00005650-197909000-00003, 480998.
17. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health surveys adequate?. Quality of Life Reseasrch 1995, 4:293-307.
18. Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, Stein REK. Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research 2002, 11:193-205. 10.1023/A:1015291021312, 12074258.
19. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey manual and interpretation guide. 1993, Boston, Massachusetts: Nimrod Press.
20. Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart JC, Thompson AJT. Home versus outpatient administration of intravenous steroids for multiple sclerosis relapses: a randomised controlled trial. Lancet Neurology 2006, 5:565-71. 10.1016/S1474-4422(06)70450-1, 16781986.
21. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-52.
22. Jenkinson C, Coulter A, Bruster S. The Picker Patient Experience Questionnaire: development and validation using data from in-patient surveys in five countries. International Journal for Quality in Health Care 2002, 14(5):353-358. 10.1093/intqhc/14.5.353, 12389801.
23. Department of Health Creating a patient-led NHS: delivering the NHS improvement plan. 2005, London: DoH, Department of Health.
24. Ware JE, Hays RD. Methods for measuring patient satisfaction with specific medical encounters. Med Care 1988, 26:393-401. 10.1097/00005650-198804000-00008, 3352332.
25. Jenkinson C, Coulter A, Bruster S, Richards N, Chandola T. Patient experiences and satisfaction with health care: results of a questionnaire study of specific aspects of care. Quality and Safety in Health Care 2002, 11:335-339. 10.1136/qhc.11.4.335, 1757991, 12468693.
26. Department of Health Your health, Your Care, Your Say. 2005, London: DoH, Department of Health.
27. Waksberg J. What is a Survey? How to Conduct Pretesting. 1995, Alexandria, VA: American Statistical Association.
28. Rasch G. Probabilistic models for some intelligence and attainment tests. 1960, Chicago: University of Chicago Press.
29. Lord FM, Novick MR. Statistical theories of mental test scores. 1968, Reading (MA): Addison-Wesley.